Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-064256

Chief Scientific Officer sold 11,742 shares at an average $14.08 ($165,366)

  • Chief Scientific Officer acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Michaelson Jennifer · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-20 Sale : show line 1 in the form 10b5-1 −3,742 $13.62 $50,966 181,977 D
2026-02-20 Exercise or conversion : show line 2 in the form 10b5-1 +8,000 $4.30 $34,400 189,977 D
2026-02-20 Sale : show line 3 in the form 10b5-1 −8,000 $14.30 $114,400 181,977 D
Open-market sales · 11,742 sh · avg $14.08 · $165,366

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-20 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −8,000 124,987 D
Loading xslF345X05/ownership.xml…